X4 Pharmaceuticals, Inc. (XFOR)
NCM – Real Time Price. Currency in USD
4.37
+0.09 (2.10%)
Market open: Aug 12, 2026, 11:46 AM EDT
4.28
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
4.37
+0.09 (2.10%)
Market open: Aug 12, 2026, 11:46 AM EDT
4.28
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $195.7M significantly exceed its total debt $77.2M, ensuring strong financial flexibility
Total current assets $218.9M exceed Total current liabilities $19.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.5) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-7.6x) is dangerously low, suggesting debt repayment risks
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 11.30 | 6.05 | 10 | |
| Quick ratio | 11.02 | 5.63 | 10 | |
| Debt to Equity | 0.50 | 0.30 | 7.0 | |
| Debt to Assets | 0.31 | 1.04 | 7.0 | |
| Interest coverage | -7.57 | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 3M | 35M | 16M |
| Gross Profit | -2M | -2M | 1M | 29M | 13M |
| Operating Income | -88M | -108M | -141M | -87M | -88M |
| Net Income | -94M | -101M | -37M | -79M | -90M |
| EBITDA | -86M | -106M | -141M | -86M | -86M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 28.05 | 72.17 | 10 |
| Next quarter | -12.77 | 7.27 | 3.0 |
| Current year | -61.84 | 62.57 | 5.5 |
| Next year | -23.43 | -6 | 1.0 |
| Weighted average score | 4.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 225.18 | 20.18 | 18.75 | 44.19 | 9.8 |
| Y/Y | 346.33 | 37.23 | 96.25 | 53 | 10 |
| 3y average | 1090.4 | -18.74 | 65.45 | -8.72 | 5.5 |
| 5y average | 834.04 | -20.96 | 45.83 | -10.58 | 5.5 |
| Weighted average score | 7.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |